O'Malley et al. reported a case of IDCT associated with angioimmunoblastic T-cell lymphoma and evidence of BRAF-V600E [11], and Thurner et al. reported a case of IDCT with BRAF V600E mutation in long-term remission with MEK/BRAF inhibitors [12]. The gene discussed is MAP2K7; the disease is angioimmunoblastic T-cell lymphoma.